INTRODUCTION
South Africa has a high incidence of violence and death due to high levels of interpersonal violence and motor vehicle accidents. Norman and colleagues (2007) reported a homicide rate in South Africa that was seven to nine times greater than global reported rates. The authors also reported a mortality rate related to road traffic accidents in South Africa of double the global rate. Thomson (2003) stated that trauma kills young people in the prime of their economically productive lives. Trauma is often referred to as the 'hidden epidemic' as it gets much less media attention than the human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pandemic but has an equally high mortality rate (Thomson 2003) . Survivors of trauma often present with serious injuries and illness that necessitate admission to the intensive care unit (ICU). Severity of illness determines the length of ICU and hospital stay. The 2002 Brussels Roundtable Discussions among intensive care practitioners concluded that survivors of intensive care suffered from poor functional capabilities, decreased quality of life (QOL), and decreased rate of return to work and placed an increased burden and stress on families and informal caregivers. These factors led to increased economic costs for the patient, families and the society (Angus & Carlet 2003) .
The effects of immobility and critical illness on the human body (short and long-term) are not always well-understood. The aims of this review article are to a) provide information to physiotherapists on the human body's response to trauma; b) explain the pathogenesis of muscle weakness due to inflammation and the resulting impairments that survivors present with and c) identify the role of exercise prescription in counteracting these impairments both during and after hospital stay. Figure 1 outlines the responses of body systems to trauma. Local and systemic responses are activated by various factors such as injury, surgery, burns, dehydration, sepsis and acute medical illness.
TRAUMA AND THE HUMAN BODY

Correspondence to:
Heleen Acute injury/trauma leads to loss of lean body and skeletal mass and precedes the process of recovery and wound repair. Inflammation, as a result of injury, consists of humoral [triggering of coagulation and fibrinolytic cascades as well as kinin (blood protein that acts as vasodilator during inflammation i.e. bradykinin)] and cellular (activation of leukocytes and endothelial cells) responses. Exacerbation of the inflammatory response can lead to the development of a systemic inflammatory response syndrome (SIRS) due to an imbalance in the production of proinflammatory cytokines (Hietbrink et al 2006) . Anti-inflammatory cytokines are released to restore this imbalance but over activation leads to either a compensatory anti-inflammatory response or a mixed antagonist response (Hietbrink et al 2006; Osuchowski et al 2006) . The patient's immune system is in disarray and the patient becomes very susceptible to infection which might result in septic syndrome and ultimately multiple organ dysfunction (MOD) (Hietbrink et al 2006; Osuchowski et al 2006) .
The initial response to trauma is to access energy from endogenous fat oxidation. Fat provides most of the body's energy requirements during the period in which no food is ingested. Fat is mobilized from fat stores and converted to free fatty acids and glycerol. These are then circulated to tissues such as the large muscles which can burn the fatty acids directly. Blood sugar starts to rise slowly and insulin production from the pancreas is inhibited (Boffard 2003; Winkler & Manchester 1996) . A metaanalysis of randomised controlled trials (RCT) on insulin therapy administration during critical illness showed that hyperglycemia is common in patients with critical illness and also may play a role in the activation of the tissue factor pathway of coagulation (Pittas, Siegel & Lau 2004) . This may lead to the development of acute thrombosis. The authors concluded that insulin therapy and tight glucose control had a beneficial effect on short-term morbidity and mortality (Pittas, Siegel & Lau 2004) . Hyperglycaemia may contribute to the important stimulant of aldosterone. This occurs via the renin-angiotensin system and adrenocorticotropic hormone (ACTH) both of which stimulate the adrenal cortex to produce aldosterone. Aldosterone supports circulation through decreased excretion of sodium bicarbonate through the kidneys. Blood loss also stimulates the production of vasopressin/antidiuretic hormone (ADH) from the posterior pituitary, with consequent fluid retention and vasoconstriction of the large blood vessels. Increased catecholamine secretion is the main endocrine response to trauma. These catecholamines, especially epinephrine, inhibit insulin production and increase insulin resistance. This causes an initial, slight elevation of the blood sugar and a gradual rise in glucagon levels (Boffard 2003; Davis 2001 ). patient's mortality rate. Gale and coworkers recently published results from a retrospective study that was performed on all trauma patients in their urban hospital (Gale et al 2007) . They found that poor glycaemic control was associated with increased morbidity and mortality in critically ill trauma patients and was more pronounced in non-diabetic patients. They also found a greater prevalence of urinary tract infections and complications in non-diabetic trauma patients with poor glycaemic control. These results have prompted many South African trauma surgeons to treat their patients, regardless of admission diagnosis, with insulin therapy to maintain glucose levels within the normal range during their ICU stay.
Trauma also disrupts endocrine homeostasis. Blood loss is the most Trauma patients often develop circulatory shock due to severe blood loss, myocardial contusion, cardiac tamponade, tension pneumothorax or spinal injury. Shock leads to the development of various degrees of cellular damage, depletion of cellular energy stores (ATP), myocardial dysfunction, oliguria (decrease in urine output) and splanchnic ischaemia due to hypoperfusion. Hyperventilation occurs due to lactic acidosis and reduced pulmonary blood flow that leads to ventilation-perfusion mismatch and shunting (Schiller & Anderson 2001; Tatsumi et al 2000) . SIRS results in capillary leak associated with the development of the acute respiratory distress syndrome (ARDS) manifested by progressive posterior atelectasis. Respiratory muscle fatigue from muscle hypoperfusion and increased energy expenditure may lead to respiratory failure (Schiller & Anderson 2001; Skowronski 1998 ). The patient's prognosis depends on the severity of the injury, age and pre-existing illnesses. Survival depends on maintenance of oxygen delivery and effective surgical intervention (Schiller & Anderson 2001; Skowronski 1998 ).
THE INFLAMMATORY PROCESS
The human body is protected from a wide range of micro-organisms through the immune system mediated through antigen presenting cells and inflammatory cells. These cells produce proinflammatory and anti-inflammatory cytokines, lymphokines and eicosanoids that mediate the response to an inflammatory stimulus (infective or not). Pro-inflammatory mediators include interleukins (IL) 1 and 6, tumour necrosis factor-alpha (TNF-a), prostaglandins, leukotrienes and reactive oxygen species (ROS) (Grimble 1999; Mukhopadhyay, Hoidal & Mukherjee 2006) . Anti-inflammatory mediators cause immunosuppression and include IL-4, IL-10, IL-13, soluble TNF receptors and IL-1 receptor antagonist. Cytokines such as the IL and TNF-a are released into the circulation by macrophages and monocytes in inflamed tissues. Cytokines are proteins that are produced by white blood cells. IL facilitates inflammation and promotes white cell proliferation and infiltration. IL can be classified as pro-inflammatory, anti-inflammatory or have both properties (Winkelman 2004) . Research is frequently conducted on the role of IL-1, IL-6 and IL-10 in critical illness (Winkelman 2004 ).
Interleukin-1 IL-1 can be categorised as IL-1A and IL-1B. Both bind to receptors on the cell membrane (Winkelman 2004 ) and small amounts can elicit an inflammatory response throughout the body. IL-1 is therefore associated with the development of SIRS and causes clinical reactions such as fever, malaise and loss of appetite and sleep (Winkelman 2004) . IL-1 promotes the adhesion of leukocytes to the endothelium resulting in capillary leak, stimulates the production of white blood cells from bone marrow and promotes prostaglandin production. Both IL-1A and IL-1B are toxic to muscle tissue (Winkelman 2004) . IL-1A influences insulin-growth factor and this leads to muscle protein breakdown. IL-1B is known to be involved with apoptosis (planned cell death with subsequent phagocytosis by other cells) and contributes to the reduction of muscle mass (Winkelman 2004 ).
Interleukin-6
IL-6 is released from T-cells, mast cells, epithelial cells, pulmonary epithelial cells and myocytes. It stimulates the activation of neutrophils and natural killer cells with further release of IL-1 and TNF-α. It enhances B-cell production as well as antibody production by B-cells (Winkelman 2004 ) and as inflammation becomes chronic it slows the production of IL-1 and TNF-α and promotes the release of anti-inflammatory mediators. Research has shown that persistently high levels of circulating IL-6 are associated with an increased risk of mortality in patients suffering from sepsis, trauma or burns (Winkelman 2004 ). IL-6 enhances the infiltration of myocytes with prostaglandins, which leads to breakdown of protein, dege neration of myocytes and muscle atrophy. IL-6 has been associated with maintenance of homeostasis during exercise through the regulation of glucose meta bolism by skeletal muscles (Winkelman 2004 ).
Interleukin-10
IL-10 is an anti-inflammatory cytokine that inhibits the production of proinflammatory cytokines by macrophages or monocytes. Low levels of IL-10 in the ICU patient can be associated with excessive inflammation and muscle damage and lead to the development of SIRS. High levels of IL-10 may provide protection against inflammatory myopathy. Myocyte damage as a result of disease progression is best controlled by maintaining a balance between proinflammatory cytokines (IL-1 and IL-6) and anti-inflammatory cytokines (IL-10) (Pretorius 2003; Winkelman 2004 ).
Tumour Necrosis Factor-Alpha TNF-α is released into the circulation during the early phase of injury or infection. TNF-α produces similar metabolic and physiologic actions to IL-1 (Grimble 1999; Mukhopadhyay, Hoidal & Mukherjee 2006) .
Reactive Oxidant Mediated Injury
Recent developments in the medical literature propose that systemic oxidative stress plays a role in the development and manifestation of critical illness. Oxidative stress has been defined as "a condition in which accumulation of free radicals or the inability of antioxidants to counter the accumulation of free radicals creates an imbalance between production of ROS and protection of antioxidants" (Goodyear-Bruch & Pierce 2002, pp 545) . In health small amounts of ROS are essential to life, forming a major component of our intrinsic defence systems in the form of phagocyte derived hydrogen peroxide and hypochlorous acid. These and others that are produced as by-products of normal metabolism, (such as purine and arachidonic acid metabolism) are neutralized by the major endogenous anti-oxidants glutathione, catalase, superoxide dismutase and albumin and exogenous antioxidants such as vitamin C, vitamin E, β carotene and selenium. However in 
Pathogenesis of Muscle Weakness
TNF-a increases the production of catabolic cytokines (IL-1 and IL-6) and causes anorexia (Jackman & Kandarian 2004; Reid & Li 2001; Winkelman 2004 ). This catabolic effect leads to the disruption of myogenesis (formation of muscle tissue) (Andreoli et al 1993) . It causes muscle breakdown in inflammatory diseases such as cancer, chronic obstructive pulmonary disease (COPD), AIDS and sepsis, which contributes to weakness, fatigue and limited mobility (Reid & Li 2001) . TNF-α binds to Type 1 TNF-α receptors leading to an increased production of ROS from mitochondrial electron transport chains in skeletal muscle (Reid & Li 2001) . Nuclear factor-κB is activated causing increased activity of the ubiquitin/proteasome pathway that accelerates degradation of the bulk of all intracellular proteins, especially myofibrillary protein and promotes muscle weakness (Jackman & Kandarian 2004; Reid & Li 2001; Winkelman 2004) . Reid compared the effect of TNF-α on the contractile function of a murine diaphragm and the flexor digitorum brevis muscle. They found that TNF-α induced contractile dysfunction on both muscles through its effect on the myofilaments. They stated that TNF-α promotes the production of ROS and nitric oxide derivatives (Reid, Lännergren & Westerblad 2002) .
Jackman and Kandarian postulated that TNF-a and other cytokines act as triggers for muscle wasting due to the effect of cachexia on the body as a whole. They stated that ROS contribute to the cytokine-induced muscle wasting (Jackman & Kandarian 2004) . Lanone and colleagues (2000) investigated the effects of sepsis on muscle contractile failure in a group of 16 patients. Biopsies from the rectus abdominis muscles were compared with biopsies taken from patients without sepsis that underwent elective surgery. The authors found a marked decrease in the contractile force of the rectus abdominis muscles of patients with sepsis compared to the controls. They ascribed this finding to the fact that high levels of nitric oxide synthase were present in the muscle samples taken from patients with sepsis. Nitric oxide synthase leads to the production of nitric oxide which interacts with ROS to form peroxynitrites that directly attack contractile proteins (Lanone et al 2000) . Eikermann and colleagues (2006) performed a similar experiment on patients that had survived sepsis and MOD syndrome. They investigated the effect of sepsis and MOD syndrome on the strength and fatigue of the adductor pollicis (AP) muscle. They found that AP muscle force was significantly decreased (by 30%) compared with controls but that no fatigability was observed. They concluded that the decrease in muscle force was due to a sepsis-induced myopathy as the compound muscle action potential and nerve conduction velocity was normal, implying no neural injury (Eikermann et al 2006) .
Prolonged immobilisation and its effect on the human body
The physical deconditioning that result from prolonged bed rest is not new to medical science. Hippocrates described loss of muscle strength and reduced exercise performance following prolonged bed rest and inactivity in the earliest medical journals. Bed rest is generally an unavoidable consequence of critical illness (Convertino, Bloomfield & Green leaf 1997; Winkelman 2004) . The adverse effects of prolonged bed rest in the supine position include loss of hydrostatic pressure in the cardiovascular system below the level of the heart; elimination of longitudinal compressive forces on the lower limbs and spine with reduced muscle force exerted on all weight bearing bones; a significant decrease in total energy utilization and detrimental effects on the musculoskeletal system with regard to muscle power, endurance and size of muscle fibres (Convertino, Bloomfield & Greenleaf 1997) . This results in weakness and easy fatigability of the diaphragm and skeletal muscles (Winkelman 2004 ). Disuse atrophy is exacerbated by the effects of steroids and neuromuscular blocking agents on the muscle fibres (Bolton 1996), malnutrition and the inflammatory response and prolonged periods of continuous mandatory ventilation (Winkelman 2004) .
The Effect of Exercise on Serum Levels of Pro-And Anti-Inflammatory Cytokines IL-6 generally increases within the muscle in response to exercise. The IL-6 cytokine has a complex action and has been referred to as 'good guy or bad guy' (Pederson et al 2007) . An important finding in healthy subjects regarding IL-6 is that during exercise its function changes from pro-inflammatory to antiinflammatory. IL-6 inhibits TNF alpha production and enhances insulin uptake (Pederson et al 2007) .
Winkelman suggests that exercise can influence the serum levels of pro-and anti-inflammatory cytokines by restoring the imbalance that exists during critical illness and suggests that exhaustive exercise has the potential to increase the levels of IL-6, IL-10 and TNF-α dramatically (Winkelman 2004) . Similar effects of exhaustive exercise on the release of ROS were reported by Kalokerinos (2005) . Moderate exercise slows the atrophic changes that occur due to disuse by improving blood flow to muscles and joints. Therapeutic activities that are performed by physiotherapists and nursing staff on patients in the ICU include positional changes from supine to side lying, passive joint range of motion (ROM) movements, sitting up over the side of the bed and transferring from bed to chair. Winkelman and colleagues studied the effect of low-level activity (position changes and passive ROM movements) on the levels of IL-6 and IL-10 in a group of 10 patients with prolonged MV. They reported that activity did not exacerbate the levels of circulating IL-6 and IL-10 and that low-level activity in the ICU may play a role in restoring the balance in cytokine activity. The small sample size however restricted the interpretation of their findings (Winkelman et al 2007) . There exists no clinical research data regarding the appropriate intensity, frequency or mode of exercise in the acutely ill patient. Stiller and Phillips (2003) suggest that exercise intensity, frequency and mode be adjusted to each individual patients' medical condition and level of debilitation. These authors recommend starting with low level activities (bed exercises and lifting of the patient into a chair) that are gradually progressed to basic mobility (standing and walking) (Stiller & Phillips 2003) .
In summary, inflammation inhibits the production of protein and the protein content of muscle tissue. This leads to loss of muscle mass and power. Inactivity, in the presence of inflammation, may contribute to the destruction of muscle cells. IL-1, IL-6 and TNF-α are involved in muscle breakdown during an inflammatory reaction whereas IL-10 inhibits the actions of the abovementioned cytokines. Low-level exercise may slow the atrophic changes that occur due to disuse by improving blood flow to muscles and joints provided the patient is not too sedated to participate in these exercises.
Exercise and its potential role inrehabilitation
It is well known that physical fitness plays a key role in a person's ability to perform activities of daily living (ADL). Physical fitness also influences their ability to participate in sport and exercise and aids in improving QOL (Blair, LaMonte & Nichaman 2004) , through the known effects on the musculoskeletal, respiratory and cardiovascular systems (Warburton, Nicol & Bredin 2006) . As discussed above, prolonged bed rest results in muscle weakness, poor muscle endurance and rapid loss of calcium from bone (Conroy & Earle 2000; Convertino, Bloomfield & Greenleaf 1997) . Other beneficial effects of exercise are increased muscle mass and strength due to a) improved neural control, b) increased muscle cross-sectional area, c) new bone formation stimulated through weight-bearing exercises, d) increased synthesis of high-density lipoproteins and improved insulin sensitivity (Taylor, Bell & Lough 2002) . Muscles develop new capillaries which increase the oxygen extraction ratio. More skeletal muscle cell mitochondria are produced as a result of aerobic exercise and maximal oxygen uptake improves as physical fitness improves (Williams 2000) . As maximal oxygen uptake increases, less energy is utilized to perform ADL and health-related QOL improves.
Rehabilitation programmes that consist of aerobic and resistance exercises are commonly used in the chronic cardiac and pulmonary disease populations with encouraging results (AACVPR 2004). Jones and co-workers (2003) are the only researchers to date to test the effectiveness of a rehabilitation programme on the recovery of survivors of critical illness in a RCT. They compiled a 93-page rehabilitation package that consisted of a self-directed exercise programme, diagrams and illustrations. The manual also contained advice on a wide range of psychological, psychosocial and physical problems that the ICU survivor could expect to encounter after they had recovered from critical illness. Subjects (n = 69) and controls (n = 57) were contacted telephonically three times per week after discharge to monitor progress however subjects in the experimental group were also encouraged to use the self-help rehabilitation manual. All subjects were tested at follow-up clinics at eight weeks and six months. The authors found that the SF-36 physical function score for subjects in the experimental group was closer to normal and significantly different from those in the control group (Jones et al 2003) .
There are few studies that investigated the effects of critical illness on recovery of exercise capacity in survivors over the first six months to one year after discharge. Herridge and colleagues (2003) evaluated the outcome of 109 adult survivors of ARDS over a oneyear period following discharge. These patients had a median injury severity score (APACHE II) of 23, median ICU length of stay (LOS) of 25 days and a median hospital LOS of 48 days. They found that survivors of ARDS still had limitations in functional abilities one year following discharge. They ascribed this to the severity of muscle wasting that took place in hospital and the resultant weakness that persisted after discharge. They emphasized that extrapulmonary disease was the main cause of limitations in exercise capacity in these subjects (Herridge et al 2003) . Hui and colleagues (2005) examined the impact of severe acute respiratory syndrome (SARS) on the recovery of 110 survivors at three and six months following discharge from ICU. A mean hospital LOS of 32.4 days was reported. The authors reported that survivors of SARS had significantly lower levels of functional ability and health status when compared to the normal population at six months. They ascribed these findings to muscle deconditioning and steroidinduced myopathy (Hui et al 2005) .
Due to the deconditioning that patients present with after prolonged bed rest, the only form of aerobic exercise they perform comfortably and conveniently is walking (Warburton, Nicol & Bredin 2006) . Walking involves the large muscle groups and has few, if any, side effects and has potential benefits of aerobic exercise (Morris & Hardman 1997) . Stiller and Phillips (2003) suggests 50 -60% of maximal HR as a baseline level of intensity for increasing patient fitness after discharge. The introduction of resistance and flexibility exercises for survivors of critical illness for upper and lower limb as well as trunk muscles should be done gradually in order to allow for wound healing to take place.
CONCLUSION
There is a dearth of literature on the recovery of muscle strength and exercise capacity in survivors of critical illness over the first 12 months after discharge from the hospital. Physiotherapists need to be aware of the pathogenesis of muscle weakness during critical illness and how their interventions (exercise) influence patient outcome in and after ICU.
